Results 151 to 160 of about 2,155 (206)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies. [PDF]

BMC Health Serv Res, 2019
Pochopien M, Beiderbeck A, McEwan P, Zur R, Toumi M, Aballéa S.   +5 more
europepmc   +1 more source

Delayed-Onset Wound Leakage and Endophthalmitis After Intravitreal Implantation of Fluocinolone Acetonide. [PDF]

J Vitreoretin Dis
Chang PS, Yu JH, Chun DW, Ali MH, Levinson JD, Do BK, Melamud A.   +6 more
europepmc   +1 more source

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy. [PDF]

Eye (Lond), 2017
Meireles A, Goldsmith C, El-Ghrably I, Erginay A, Habib M, Pessoa B, Coelho J, Patel T, Tadayoni R, Massin P, Atorf J, Augustin AJ.   +11 more
europepmc   +1 more source

Acute postoperative complications after scleral fixation of Akreos AO60 intraocular lens. [PDF]

J Surg Case Rep
Grassi P, Tsoutsanis P, Henderson R.
europepmc   +1 more source

Clinical effectiveness of the 0.18 mg fluocinolone acetonide intravitreal implant for non-infectious uveitis-associated macular edema: a real-world study. [PDF]

BMC Ophthalmol
Chen C, Zhang WJ, Ding Q, Shen SM, Ye Y, Huang Z, Yan M, Song YP.   +7 more
europepmc   +1 more source

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response. [PDF]

J Vitreoretin Dis
Bello NR, Wang RC, Boss J, Singer M, Hopkins S, Billawala K, Henry CR, Mammo DA.   +7 more
europepmc   +1 more source

Intravitreal fluocinolone acetonide 0.19 mg Iluvien implant for radiation maculopathy

Canadian Journal of Ophthalmology
Paul T. Finger, Shayri Pillai, Ankit Singh Tomar   +2 more
openaire   +1 more source

Comment on the Review: Clarifying Steroid-Associated Glaucoma-From Association to an Actionable Closed-Loop [Letter]. [PDF]

J Inflamm Res
Xu L, Chen X, Liu G.
europepmc   +1 more source

Impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes. [PDF]

Eye (Lond)
Kozak I, Khoramnia R, Taylor SR, Chakravarthy U, ILUVIEN Registry Safety Study (IRISS) Investigators Group.   +4 more
europepmc   +1 more source